Biotechs have healthy upside - The Australian Financial Review

manuscripts-shuwatu.blogspot.com

Biotechs have healthy upside The Australian Financial Review Bell Potter senior analyst Stuart Roberts said investors have been wary of the sector, but you only have to look at the share price of Acrux to see the dramatic response once the business becomes viable. Acrux shares have surged 144 per cent over the ...